AI Science Tracker
EN

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

Research Institute of Fundamental and Clinical Immunology; Novosibirsk State University · 30 Nov 2024 · medicine

Discovery

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Single-cell sequencing plus TCRscape clonotype counts and ERGO-II neural-network binding scores selected a HER2-specific TCR among seven healthy donors; transduced T cells showed differential in-vitro cytotoxicity across antigen-expression cell lines. Experimental proof-of-concept, not a clinical therapy outcome.

Technology: Single-cell sequencing plus TCRscape clonotype counts and ERGO-II neural-network binding scores selected a HER2-specific TCR among seven healthy donors; transduced T cells showed differential in-vitro cytotoxicity across antigen-expression cell lines

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Single-cell sequencing plus TCRscape clonotype counts and ERGO-II neural-network binding scores selected a HER2-specific TCR among seven healthy donors; transduced T cells showed differential in-vitro cytotoxicity across antigen-expression cell lines
Limitation / still unknown
The findings are limited to the reported dataset, experimental setup and validation described in the source; broader generalization and real-world benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.mdpi.com/2072-6694/16/23/4020 · https://pubmed.ncbi.nlm.nih.gov/39682207/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.